One-Stop Shop for Drug Development Processes

Bratislava, Slovakia

SanaClis was recognized by Pharma Tech Outlook Magazine as one of the Top 10 CROs in Europe 2018. An annual listing of 10 CROs that are spearheading innovation and impact in the industry.

“We offer a boutique, one-stop solution for clinical trials that make a huge positive impact on the deliverables of our biopharma clients. Our services are in-house; we have a near-perfect track record of on-time delivery with more than 95 percent of our projects delivered on or before the stipulated time frame and on budget,” begins Alexander Fetkovsky, Managing Partner at SanaClis. With such a commendable track record, a full-service clinical research organization (CRO), SanaClis offers a comprehensive range of services for clinical trials and ensures an easy as well as fast drug development process for Pharma and Biotech companies. The broad range of services that SanaClis purveys to pharma companies includes clinical monitoring, IP & CTS management, customs clearance and brokerage along with quality and data management. The company also houses logistics capabilities that include qualified person (QP) services, customs brokerage, warehousing, distribution, and sourcing. 

SanaClis’s clinical monitoring services for various therapeutic areas cover the drug development processes from the phase I to phase IV. “Our clinical specialist can support every step of the project from feasibility process, selecting the study sites, study sites monitoring and collecting the data. Our Data Management department has years of experience of setting up and working with EDC systems. On top of our GCP experts we can also support our client’s needs with our experts and dedicated facilities for Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP),” says Fetkovsky.

SanaClis does not only offer a wide range of clinical trial expertise to its clients but builds with them relationship based on transparency, trust and quality. Clients especially value the dedication of staff working on their projects and as well as a near-zero turnover rate on projects: this is possible due to strong company focus on employees, offering pleasant and healthy working environment and a wide range of company benefits.

For the future, SanaClis’s goal is to expand its operations into North America. The company has also observed significant surge in demand for its supply chain services and plans to expand it within the European Union by the next half of 2019.